It may not be the best idea to be using a 401K to invest in biotech . Holding thru
the impending data drop without significant downside protection could be a disaster .
The risk reward for the type of stocks Bone is recommending is by the very nature of
scientific acceptance often an asymmetrical conclusion to the downside .
I haven't been in a 401K for many many years but I do not believe there are any vehicles
to protect a large winning position. Just my opinion .